Work-related problems in multiple sclerosis: A literature review on its associates and determinants

Disability and Rehabilitation

Volumn 38, Issue 10, 2016, Pages 936-944

  Raggi, Alberto ^a   Covelli, Venusia ^a   Schiavolin, Silvia ^a   Scaratti, Chiara ^a   Leonardi, Matilde ^a   Willems, Michelle ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

Employment; ICF classification; multiple sclerosis; review; work

Indexed keywords

ADULT; CROSS-SECTIONAL STUDY; DISABLED PERSON; EMPLOYMENT; FATIGUE; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; PSYCHOLOGY; RETROSPECTIVE STUDY; UNEMPLOYMENT; WALKING; WALKING DIFFICULTY;

ADULT; CROSS-SECTIONAL STUDIES; DISABLED PERSONS; EMPLOYMENT; FATIGUE; FEMALE; HUMANS; MALE; MIDDLE AGED; MOBILITY LIMITATION; MULTIPLE SCLEROSIS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; UNEMPLOYMENT; WALKING;

EID: 84959554349     PISSN: 09638288     EISSN: 14645165     Source Type: Journal    
DOI: 10.3109/09638288.2015.1070295     Document Type: Article

References (87)

1. Pugliatti M, Rosati G, Carton H, et al. The epidemiology of multiple sclerosis in Europe. Eur J Neurol 2006; 13: 700-22
2. Gustavsson A, Svensson M, Jacobi F, et al.; CDBE2010Study Group. Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 2011; 21: 718-79
3. Confavreux C, Compston A. The natural story of MS. In: Compston A, Confavreux C, Lassmann H, et al., eds. McAlpines multiple sclerosis, 4th ed. London: Churchill Livingstone Elsevier; 2006: 183-269
4. Compston A, Coles A. Multiple sclerosis. Lancet 2008; 372: 1502-17
5. Kobelt G, Berg J, Lindgren P, Jönsson B. Costs and quality of life in multiple sclerosis in Europe: method of assessment and analysis. Eur J Health Econ 2006; 7: s5-13
6. Schiavolin S, Leonardi M, Giovannetti AM, et al. Factors related to difficulties with employment in patients with multiple sclerosis: a review of 2002-2011 literature. Int J Rehabil Res 2013; 36: 105-11
7. National Institute for Health and Clinical Excellence. The guideline manual. London: National Institute for Health and Clinical Excellence; 2009
8. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444-52
9. Popay J, Roberts H, Sowden A, et al. Guidance on the conduct of narrative synthesis in systematic reviews A product from the ESCR methods Programme. Lancaster: ESRC Methods Program; 2006
10. Cabello M, Mellor-Marsá B, Sabariego C, et al. Psychosocial features of depression: a systematic literature review. J Affect Disord 2012; 141: 22-33
11. Quintas R, Raggi A, Giovannetti AM, et al. Psychosocial difficulties in people with epilepsy: a systematic review of literature from 2005 until 2010. Epilepsy Behav 2012; 25: 60-7
12. Raggi A, Giovannetti AM, Quintas R, et al A systematic review of the psychosocial difficulties relevant to patients with migraine. J Headache Pain 2012; 13: 595-606
13. ͆witaj P, Anczewska M, Chrostek A, et al. Disability and schizophrenia: a systematic review of experienced psychosocial difficulties. BMC Psychiatr 2012; 12: 193
14. Levola J, Kaskela T, Holopainen A, et al. Psychosocial difficulties in alcohol dependence: a systematic review of activity limitations and participation restrictions. Disabil Rehabil 2014; 36: 1227-39
15. Krokavcova M, Nagyova I, Van Dijk JP, et al. Self-rated health and employment status in patients with multiple sclerosis. Disabil Rehabil 2010; 32: 1742-8
16. Busche KD, Fisk JD, Murray TJ, Metz LM. Short term predictors of unemployment in multiple sclerosis patients. Can J Neurol Sci 2003; 30: 137-42
17. Strober LB, Christodoulou C, Benedict RH, et al. Unemployment in multiple sclerosis: the contribution of personality and disease. Mult Scler 2012; 18: 647-53
18. Glad SB, Aarseth JH, Nyland H, et al. Benign multiple sclerosis: a need for a consensus. Acta Neurol Scand Suppl 2010; 122(suppl 190): 44-50
19. Glad SB, Nyland H, Aarseth JH, et al. How long can you keep working with benign multiple sclerosis? J Neurol Neurosurg Psychiatr 2011; 82: 78-82
20. O'Connor RJ, Cano SJ, Ramió i Torrentà L, et al. Factors influencing work retention for people with multiple sclerosis: cross-sectional studies using qualitative and quantitative methods. J Neurol 2005; 252: 892-6
21. Wickström A, Nyström J, Svenningsson A. Improved ability to work after one year of natalizumab treatment in multiple sclerosis: analysis of disease-specific and work-related factors that influence the effect of treatment. Mult Scler 2013; 19: 622-30
22. Olofsson S, Wickström A, Häger Glenngård A, et al. Effect of treatment with natalizumab on ability to work in people with multiple sclerosis: productivity gain based on direct measurement of work capacity before and after 1 year of treatment. BioDrugs 2011; 25: 299-306
23. Smith MM, Arnett PA. Factors related to employment status changes in individuals with multiple sclerosis. Mult Scler 2005; 11: 602-9
24. Ruet A, Deloire M, Hamel D, et al. Cognitive impairment, health-related quality of life and vocational status at early stages of multiple sclerosis: a 7-year longitudinal study. J Neurol 2013; 260: 776-84
25. Simmons RD, Tribe KL, McDonald EA. Living with multiple sclerosis: longitudinal changes in employment and the importance of symptom management. J Neurol 2010; 257: 926-36
26. Julian LJ, Vella L, Vollmer T, et al. Employment in multiple sclerosis. Exiting and re-entering the work force. J Neurol 2008; 255: 1354-60
27. Flensner G, Landtblom AM, Söderhamn O, Ek AC. Work capacity and health-related quality of life among individuals with multiple sclerosis reduced by fatigue: a cross-sectional study. BMC Public Health 2013; 13: 224
28. Bøe Lunde HM, Telstad W, Grytten N, et al. Employment among patients with multiple sclerosis-A population study. PLoS One 2014; 9: e103317
29. Patten SB, Williams JV, Lavorato DH, et al. Depression as a predictor of occupational transition in a multiple sclerosis cohort. Funct Neurol 2013; 28: 275-80
30. Krokavcova M, Nagyova I, Rosenberger J, et al. Employment status and perceived health status in younger and older people with multiple sclerosis. Int J Rehabil Res 2012; 35: 40-7
31. Frndak SE, Kordovski VM, Cookfair D, et al. Disclosure of disease status among employed multiple sclerosis patients: association with negative work events and accommodations. Mult Scler 2015; 21: 225-34
32. Casado V, Martínez-Yélamos S, Martínez-Yélamos A, et al. Direct and indirect costs of Multiple Sclerosis in Baix Llobregat (Catalonia, Spain), according to disability. BMC Health Serv Res 2006; 6: 143
33. Honarmand K, Akbar N, Kou N, Feinstein A. Predicting employment status in multiple sclerosis patients: the utility of the MS functional composite. J Neurol 2011; 258: 244-9
34. Doward LC, Meads DM, Fisk J, et al. International development of the Unidimensional Fatigue Impact Scale (U-FIS). Value Health 2010; 13: 463-8
35. Sayao AL, Bueno AM, Devonshire V, Tremlett H,;,. UBC MS Clinic Neurologists. The psychosocial and cognitive impact of longstanding 'benign' multiple sclerosis. Mult Scler 2011; 17: 1375-83
36. Benedict RH, Wahlig E, Bakshi R, et al. Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change. J Neurol Sci 2005; 231: 29-34
37. Glanz BI, Dégano IR, Rintell DJ, et al. Work productivity in relapsing multiple sclerosis: associations with disability, depression, fatigue, anxiety, cognition, and health-related quality of life. Value Health 2012; 15: 1029-35
38. Jacobs LD, Wende KE, Brownscheidle CM, et al A profile of multiple sclerosis: the New York State Multiple Sclerosis Consortium. Mult Scler 1999; 5: 369-76
39. Chwastiak LA, Gibbons LE, Ehde DM, et al. Fatigue and psychiatric illness in a large community sample of persons with multiple sclerosis. J Psychosom Res 2005; 59: 291-8
40. Messmer Uccelli M, Specchia C, Battaglia MA, Miller DM. Factors that influence the employment status of people with multiple sclerosis: a multi-national study. J Neurol 2009; 256: 1989-96
41. Van der Hiele K, Middelkoop HA, Ruimschotel R, et al A pilot study on factors involved with work participation in the early stages of multiple sclerosis. PLoS One 2014; 9: e105673
42. Honan CA, Brown RF, Hine DW, et al. The multiple sclerosis work difficulties questionnaire. Mult Scler 2012; 18: 871-80
43. Flensner G, Ek AC, Landtblom AM, Söderhamn O. Fatigue in relation to perceived health: people with multiple sclerosis compared with people in the general population. Scand J Caring Sci 2008; 22: 391-400
44. Wickström A, Dahle C, Vrethem M, Svenningsson A. Reduced sick leave in multiple sclerosis after one year of natalizumab treatment: a prospective ad hoc analysis of the TYNERGY trial. Mult Scler 2014; 20: 1095-101
45. Ehde DM, Osborne TL, Hanley MA, et al. The scope and nature of pain in persons with multiple sclerosis. Mult Scler 2006; 12: 629-38
46. Morrow SA, Drake A, Zivadinov R, et al. Predicting loss of employment over three years in multiple sclerosis: clinically meaningful cognitive decline. Clin Neuropsychol 2010; 24: 1131-45
47. Einarsson U, Gottberg K, von Koch L, et al. Cognitive and motor function in people with multiple sclerosis in Stockholm County. Mult Scler 2006; 12: 340-53
48. Jongen PJ, Wesnes K, van Geel B, et al.; COGNISEC Study Group. Relationship between working hours and power of attention, memory, fatigue, depression and self-efficacy one year after diagnosis of clinically isolated syndrome and relapsing remitting multiple sclerosis. PLoS One 2014; 9: e96444
49. Williams AE, Vietri JT, Isherwood G, Flor A. Symptoms and association with health outcomes in relapsing-remitting multiple sclerosis: results of a US patient survey. Mult Scler Int 2014; 2014: 203183
50. Tan-Kristanto S, Kiropoulos LA. Resilience, self-efficacy, coping styles and depressive and anxiety symptoms in those newly diagnosed with multiple sclerosis. Psychol Health Med 2015; 20: 635-45
51. Salter AR, Cutter GR, Tyry T, et al. Impact of loss of mobility on instrumental activities of daily living and socioeconomic status in patients with MS. Curr Med Res Opin 2010; 26: 493-500
52. Raggi A, Giovannetti AM, Schiavolin S, et al. Development and validation of the multiple sclerosis questionnaire for the evaluation of job difficulties (MSQ-Job). Acta Neurol Scand 2015. [Epub ahead of print]. DOI: 10.1111/ane.12387
53. Ford HL, Gerry E, Johnson MH, Tennant A. Health status and quality of life of people with multiple sclerosis. Disabil Rehabil 2001; 23: 516-21
54. Forbes A, While A, Mathes L, Griffiths P. Health problems and health-related quality of life in people with multiple sclerosis. Clin Rehabil 2006; 20: 67-78
55. Bombardier CH, Blake KD, Ehde DM, et al. Alcohol and drug abuse among persons with multiple sclerosis. Mult Scler 2004; 10: 35-40
56. Rinker JR II, Salter AR, Walker H, et al. Prevalence and characteristics of tremor in the NARCOMS multiple sclerosis registry: a cross-sectional survey. BMJ Open 2015; 5: e006714
57. Leray E, Coustans M, Le Page E, et al. Clinically definite benign multiple sclerosis', an unwarranted conceptual hodgepodge: evidence from a 30-year observational study. Mult Scler 2013; 19: 458-65
58. Kappos L, Radue EW, O'Connor P, et al.; FREEDOMS Study Group A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. N Engl J Med 2010; 362: 387-401
59. McCormack PL. Natalizumab: a review of its use in the management of relapsing-remitting multiple sclerosis. Drugs 2013; 73: 1463-81
60. Scalfari A, Neuhaus A, Daumer M, et al. Age and disability accumulation in multiple sclerosis. Neurology 2011; 77: 1246-52
61. Iaffaldano P, Viterbo RG, Paolicelli D, et al. Impact of natalizumab on cognitive performances and fatigue in relapsing multiple sclerosis: a prospective, open-label, two years observational study. PLoS One 2012; 7: e35843
62. Svenningsson A, Falk E, Celius EG, et al.; Tynergy Trial Investigators. Natalizumab treatment reduces fatigue in multiple sclerosis. Results from the TYNERGY trial; a study in the real life setting. PLoS One 2013; 8: e58643
63. Drulovic J, Bursac LO, Milojkovic D, et al. MSQoL-54 predicts change in fatigue after inpatient rehabilitation for people with multiple sclerosis. Disabil Rehabil 2013; 35: 362-6
64. Hebert JR, Corboy JR, Manago MM, Schenkman M. Effects of vestibular rehabilitation on multiple sclerosis-related fatigue and upright postural control: a randomized controlled trial. Phys Ther 2011; 91: 1166-83
65. Judica E, Martinelli Boneschi F, Ungaro D, et al. Impact of fatigue on the efficacy of rehabilitation in multiple sclerosis. J Neurol 2011; 258: 835-9
66. Asano M, Berg E, Johnson K, et al A scoping review of rehabilitation interventions that reduce fatigue among adults with multiple sclerosis. Disabil Rehabil 2015; 37: 729-38
67. Baert I, Freeman J, Smedal T, et al. Responsiveness and clinically meaningful improvement, according to disability level, of five walking measures after rehabilitation in multiple sclerosis: a European multicenter study. Neurorehabil Neural Repair 2014; 28: 621-31
68. Vaney C, Gattlen B, Lugon-Moulin V, et al. Robotic-Assisted step training (lokomat) not superior to equal intensity of over-ground rehabilitation in patients with multiple sclerosis. Neurorehabil Neural Repair 2012; 26: 212-21
69. Nick ST, Roberts C, Billiodeaux S, et al. Multiple sclerosis and pain. Neurol Res 2012; 34: 829-41
70. Shahrbanian S, Auais M, Duquette P, et al. Does pain in individuals with multiple sclerosis affect employment? A systematic review and meta-Analysis. Pain Res Manag 2013; 18: e94-100
71. Feinstein A. Multiple sclerosis and depression. Mult Scler 2011; 17: 1276-81
72. Goretti B, Viterbo RG, Portaccio E, et al. Anxiety state affects information processing speed in patients with multiple sclerosis. Neurol Sci 2014; 35: 559-63
73. Jones KH, Ford DV, Jones PA, et al A large-scale study of anxiety and depression in people with multiple sclerosis: a survey via the web portal of the UK MS Register. PLoS One 2012; 7: e41910
74. Wood B, van der Mei IA, Ponsonby AL, et al. Prevalence and concurrence of anxiety, depression and fatigue over time in multiple sclerosis. Mult Scler 2013; 19: 217-24
75. Jongen PJ, Ter Horst AT, Brands AM. Cognitive impairment in multiple sclerosis. Minerva Med 2012; 103: 73-96
76. Chiaravalloti ND, DeLuca J. Cognitive impairment in multiple sclerosis. Lancet Neurol 2008; 7: 1139-51
77. Rosti-Otajärvi EM, Hämäläinen PI. Neuropsychological rehabilitation for multiple sclerosis. Cochrane Database Syst Rev 2014; 2: CD009131
78. OBrien AR, Chiaravalloti N, Goverover Y, Deluca J. Evidenced-based cognitive rehabilitation for persons with multiple sclerosis: a review of the literature. Arch Phys Med Rehabil 2008; 89: 761-9
79. Mattioli F, Stampatori C, Bellomi F, et al. Neuropsychological rehabilitation in adult multiple sclerosis. Neurol Sci 2010; 31: S271-4
80. Ben Ari Shevil E, Johansson S, Ytterberg C, et al. How are cognitive impairment, fatigue and signs of depression related to participation in daily life among persons with multiple sclerosis? Disabil Rehabil 2014; 36: 2012-18
81. Neath J, Roessler RT, McMahon BT, Rumrill PD. Patterns in perceived employment discrimination for adults with multiple sclerosis. Work 2007; 29: 255-74
82. Rumrill PD Jr, Roessler RT, McMahon BT, et al. Gender as a differential indicator of the employment discrimination experiences of Americans with multiple sclerosis. Work 2007; 29: 303-11
83. Khan F, Ng L, Turner-Stokes L. Effectiveness of vocational rehabilitation intervention on the return to work and employment of persons with multiple sclerosis. Cochrane Database Syst Rev 2009; 21: CD007256
84. Chiu CY, Chan F, Bishop M, et al. State vocational rehabilitation services and employment in multiple sclerosis. Mult Scler 2013; 19: 1655-64
85. Sweetland J, Riazi A, Cano SJ, Playford ED. Vocational rehabilitation services for people with multiple sclerosis: what patients want from clinicians and employers. Mult Scler 2007; 13: 1183-9
86. Honan CA, Brown RF, Hine DW. The multiple sclerosis work difficulties questionnaire (MSWDQ): development of a shortened scale. Disabil Rehabil 2014; 36: 635-41
87. Mcfadden E, Horton MC, Ford HL, et al. Screening for the risk of job loss in multiple sclerosis (MS): development of an MS-specific work instability scale (MS-WIS). Mult Scler 2012; 18: 862-70